CMP8

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

CMP8 

CMP8 是雌激素受体 (estrogen receptor) 的选择性配体，可结合到雌激素受体配体结合域。CMP8 对突变型 MGERα、MGRERα 和野生型 hERα、hERβ 的IC50 值分别为 29 nM、41 nM、1100 nM 和2200 nM。

CMP8

CMP8 Chemical Structure

CAS No. : 851107-28-3

规格 是否有货
100 mg   询价  
250 mg   询价  
500 mg   询价  

* Please select Quantity before adding items.

生物活性

CMP8, a selective ligand for estrogen receptor, binds to the mutant estrogen receptor ligand binding domain (ERLBD). CMP8 exhibits IC50 values of 29 nM , 41 nM, 1100 nM and 2200 nM for MGERα, MGRERα, hERα and hERβ, respectively[1][2].

IC50 & Target

MGERα

29 nM (IC50)

MGRERα

41 nM (IC50)

hERα

1100 nM (IC50)

hERβ

2200 nM (IC50)

体内研究
(In Vivo)

CMP8 (Compound 20h) is dosed in male Balb-c mice (4 mg/kg, ip). The plasma concentration after 4 h is 1.5-fold its EC50 in mammalian cells with a Cmax of 0.5 µM after 30 min[1][2].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

528.08

Formula

C33H34ClNO3
CAS 号

851107-28-3
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献

  • [1]. Miyazaki Y, et al. Destabilizing domains derived from the human estrogen receptor. J Am Chem Soc. 2012 Mar 7;134(9):3942-5.

    [2]. Kinzel O, et al. A structure-guided approach to an orthogonal estrogen-receptor-based gene switch activated by ligands suitable for in vivo studies. J Med Chem. 2006 Sep 7;49(18):5404-7.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务